Prestige Consumer Healthcare Inc.

NYSE:PBH

Medical - Distribution

Healthcare
$50.62 +0.49%

+$0.23 today

Market cap
$2.40B
Beta
0.35
P/E (TTM)
11.6
EPS (TTM)
$4.01
52W Low $42.62High $85.29

Volume 0.62M

Average 0.67M

PBH Cost of Revenue

Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.

Prestige Consumer Healthcare Inc.NYSE: PBH

Cost of Revenue · Q1 FY2027 · quarter ended Jun 2026

Cost of revenue growth accelerates

Q1 FY2027 cost of revenue of $129.52M rose 13.2% year over year, ahead of the +5.2% change in trailing-twelve-month cost of revenue. Sequentially, it fell 8.0% from the prior quarter. Over 3 fiscal years it compounded at +0.8% a year.

Context

  • Cost of revenue amounted to 47.2% of revenue in FY2026, up 3.0 pp from a year earlier.
  • Cost of revenue increased in 2 of the last 3 fiscal years.
  • FY2026 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +13.2% holds above the trailing-twelve-month pace of +5.2%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
$129.52M-8.0% QoQ
Last fiscal yearMar 2026
$514.07M+2.1% YoY
LTMJun 2026
$516.4M+5.2% YoY
Cost of Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+13.2%——
1 year+2.1%——
3-year CAGR+0.8%——
5-year CAGR——
10-year CAGR——

Cost of Revenue history

USD · from the income statement

Latest · FY2026
514.07M USD
Year-over-year change
+2.1%
4-year CAGR
+2.5%

Cost of Revenue vs competitors

How PBH compares with its peers on the latest reported figures

  • PBH's LTM Jun 2026 cost of revenue of $516.4M is the 5th highest of the 11 companies compared; the peer median is $378.22M.
  • Its year-over-year change of +5.2% is the 9th highest of 10, against a peer median of +21.7%.
  • Cost of revenue amounts to 46.7% of revenue for PBH, versus a peer median of 43.0%.
PBH Competitors Peer median
Cost of Revenue for PBH and competitors
Company Period LTM YoY 3-year CAGR% of revenue
PRVAPrivia Health Group, Inc.LTM Jun 2026$2.18B +27.2%+16.1%92.4%
CONConcentra Group Holdings Parent, Inc.LTM Sep 2026$1.64B +9.4%+5.6%70.1%
ICUIICU Medical, Inc.LTM Jun 2026$1.35B -11.4%-3.8%62.4%
LEGNLegend Biotech CorporationLTM Sep 2026$584.36M +63.0%+84.1%43.0%
PBHPrestige Consumer Healthcare Inc.LTM Jun 2026$516.4M +5.2%+0.8%46.7%
LIVNLivaNova PLCLTM Sep 2026$483.49M +13.8%+12.5%32.1%
ATECAlphatec Holdings, Inc.LTM Mar 2026$272.95M +36.9%+25.4%34.7%
ZLABZai Lab LimitedLTM Jun 2026$195.71M +21.7%+37.2%43.5%
CPRXCatalyst Pharmaceuticals, Inc.LTM Mar 2026$105.52M +42.1%+36.4%17.7%
HTFLHeartflow, Inc. Common StockLTM Sep 2026$43.32M +9.7%—18.2%
IRONDisc Medicine, Inc.LTM Sep 2026$0 ———
Peer median (excluding PBH) $378.22M+21.7%+20.8%43.0%

Competitors are the stored peer set for PBH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Mar 2022
FY2023
Mar 2023
FY2024
Mar 2024
FY2025
Mar 2025
FY2026
Mar 2026
Revenue1.09B1.13B1.13B1.14B1.09B
Cost of Revenue466.17M502.43M500.91M503.3M514.07M
Gross Profit620.65M625.29M624.45M634.46M574.64M
Gross Margin57.1%55.4%55.5%55.8%52.8%
Research & Development00000
Selling, General & Admin264.8M252.42M259.47M263.93M265.23M
Operating Expenses290.73M647.71M282.02M297.69M265.23M
Depreciation & Amortization32.09M32.63M30.68M30.17M31.27M
EBITDA358.84M7.87M373.86M361.99M331.11M
EBITDA Margin33.0%0.7%33.2%31.8%30.4%
Operating Income329.92M(22.42M)342.43M336.78M309.41M
Operating Margin30.4%-2.0%30.4%29.6%28.4%
Interest Income00000
Interest Expense64.29M69.16M67.16M47.63M42.34M
Other Income / Expenses(67.46M)(71.5M)(66.4M)(52.59M)(51.91M)
Income Before Tax262.46M(93.92M)276.03M284.19M257.5M
Pre-Tax Margin24.1%-8.3%24.5%25.0%23.7%
Income Tax Expense57.08M(11.61M)66.69M69.58M67.2M
Net Income205.38M(82.31M)209.34M214.61M190.3M
Net Margin18.9%-7.3%18.6%18.9%17.5%
EPS (Basic)4.09(1.65)4.214.323.93
EPS (Diluted)4.04(1.65)4.174.293.91
Weighted Avg Shares50.26M49.88M49.76M49.7M48.46M
Weighted Avg Shares (Diluted)50.84M49.89M50.18M50.08M48.72M

Prestige Consumer Healthcare Inc.

NYSE:PBH

Intrinsic Alpha fair value

Locked

Current Price

$50.62

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.